Arthritis Research & Therapy

official impact factor 4.36

Email this article to a friend

Drugs in development: bisphosphonates and metalloproteinase inhibitors

Jon B Catterall and Tim E Cawston*

Arthritis Res Ther 2003, 5:12-24 doi:10.1186/ar604

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.